Show simple item record

dc.contributor.editorMeneghetti, Fiorella
dc.contributor.editorBarlocco, Daniela
dc.date.accessioned2022-02-24T10:34:50Z
dc.date.available2022-02-24T10:34:50Z
dc.date.issued2022
dc.identifierONIX_20220224_9783036528601_37
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/78739
dc.description.abstractThis book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threat to global health, and the twenty-two published articles here reported put in evidence that the discovery and development of new antibiotics are extremely challenging. The antimicrobial research covers a wide area, spanning from the design of new compounds, also supported by molecular modeling techniques, their synthesis and characterization, and biological tests.In this context, the current crisis caused by the COVID-19 pandemic, but also older threats, such as the human immunodeficiency virus or the hepatitis C virus, require greater attention than ever.The research works described in this book provide an extremely useful example of the results achieved in the field of antibacterial drug development. The search for new chemical entities was approached starting from both natural and synthetic compounds and addressing different targets. In addition, recent findings were presented and discussed highlighting the strategies to fight bacterial resistance. Detailed references to the state-of-the-art can be found in this book.We strongly encourage the wide group of readers to explore the book that we are presenting, to get inspired to develop new approaches for the diagnosis and treatment of antibacterial diseases, and to circumvent resistance issues.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.othersaccharin
dc.subject.othertetrazole
dc.subject.other1,3,4-thiadiazole
dc.subject.otherH7PX glioma cells
dc.subject.otherantimicrobial screening
dc.subject.otherantioxidant capacity
dc.subject.otheroxidative stress
dc.subject.othernatural products
dc.subject.othermedicinal plants
dc.subject.otheranti-infective agents
dc.subject.otheralternative infection models
dc.subject.otherantibacterial
dc.subject.otheranticancer
dc.subject.otherGC-MS
dc.subject.otherLIBS
dc.subject.otherMoringa oleifera
dc.subject.otherseed extract
dc.subject.otherMRSA
dc.subject.othermarine bisindole alkaloids
dc.subject.otherantibiofilm activity
dc.subject.otheradjuvants agents
dc.subject.otherVBNC cells
dc.subject.otherindole
dc.subject.otherthioxothiazolidine
dc.subject.otherantibacterial activity
dc.subject.otherantifungal activity
dc.subject.othercomputer-aided prediction
dc.subject.otherdocking
dc.subject.otherMur B
dc.subject.otherCYP 51
dc.subject.otherplant compounds
dc.subject.otherdiarrhea
dc.subject.otherselectivity
dc.subject.othercompounds screening
dc.subject.otherquorum sensing inhibition
dc.subject.othermolecular docking
dc.subject.otherAMP
dc.subject.otherantimicrobial activity
dc.subject.otherantiviral activity
dc.subject.otherbacteriocin
dc.subject.otherCOVID-19
dc.subject.otherdisinfectant
dc.subject.otherLactobacillus plantarum
dc.subject.otherplantaricin
dc.subject.othercarbon nanotubes
dc.subject.otherquaternary ammonium groups
dc.subject.otherhyperbranched dendritic polymers
dc.subject.otherantibacterial properties
dc.subject.otheranti-cyanobacterial properties
dc.subject.other3D-printing
dc.subject.otherdental polymer
dc.subject.otherantibacterial agent
dc.subject.othercoating
dc.subject.othermesoporous silica nanoparticles
dc.subject.otherpolydimethylsiloxane
dc.subject.otherLeishmania tropica and infantum
dc.subject.otherantileishmanial agents
dc.subject.otherlucanthone analogues
dc.subject.otheramitriptyline analogues
dc.subject.otherquinolizidine-derived compounds
dc.subject.othermolecular modelling studies
dc.subject.othercovalent inhibitor
dc.subject.otherMurA
dc.subject.othercyclobutenaminone
dc.subject.otherirreversible
dc.subject.othermethicillin-resistant Staphylococcus aureus
dc.subject.otheressential oils
dc.subject.otherOriganum majorana
dc.subject.otherRosmarinus officinalis
dc.subject.otherThymus zygis
dc.subject.otherbiofilm inhibition and eradication
dc.subject.otherurushiol
dc.subject.other3-pentylcatechol
dc.subject.other3-pentadecylcatechol
dc.subject.otherHelicobacter pylori
dc.subject.otherantimicrobial
dc.subject.othertriple therapy
dc.subject.otheratopic dermatitis
dc.subject.otherskin barrier
dc.subject.othercutaneous dysbiosis
dc.subject.otherStaphylococcus aureus
dc.subject.othermicrobial therapy
dc.subject.otherdrug delivery systems
dc.subject.othertris(1H-indol-3-yl)methylium
dc.subject.otherturbomycin
dc.subject.otherindole derivatives
dc.subject.otherantibacterial action
dc.subject.otherovercoming of drug resistance
dc.subject.otherbiological activities
dc.subject.otheressential oil
dc.subject.otherextract
dc.subject.otherThymus mastichina
dc.subject.otherimidazole and imidazolium salts
dc.subject.otheramino acid
dc.subject.otherantibacterial agents
dc.subject.otheraggregation
dc.subject.otherlipophilicity
dc.subject.otherantimicrobial peptide
dc.subject.otherbiomembranes
dc.subject.otherESKAPE
dc.subject.otherantibiotic resistance
dc.subject.otherNMR
dc.subject.othermolecular dynamics
dc.subject.otherbiophysics
dc.subject.othersequence alignment
dc.subject.otherlytic infection
dc.subject.otherantibiotic-resistance
dc.subject.otherMycobacterium tuberculosis
dc.subject.otherAcinetobacter baumannii
dc.subject.otherPseudomonas aeruginosa
dc.subject.otherphage production
dc.subject.othermagistral phage
dc.subject.otherpulmonary delivery
dc.subject.otheroral administration
dc.subject.othertopical delivery
dc.subject.otherPinus cembra L.
dc.subject.otherPinus mugo Turra
dc.subject.otherPicea abies L.
dc.subject.otherAbies alba M.
dc.subject.otherchemical investigation
dc.subject.otherHS-GC/MS
dc.subject.otherantioxidant activity
dc.subject.othertuberculosis
dc.subject.othermycobactins
dc.subject.otherfuran
dc.subject.othersiderophores
dc.subject.otherdrug design
dc.subject.otherbioisosterism
dc.subject.otherdrug resistance
dc.subject.othern/a
dc.titleNovel Antibacterial Agents
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-2860-1
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036528601
oapen.relation.isbn9783036528618
oapen.pages409
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/